Congenital adrenal hyperplasia: management during critical illness

被引:18
作者
Charmandari, E
Lichtarowicz-Krynska, EJ
Hindmarsh, PC
Johnston, A
Aynsley-Green, A
Brook, CGD
机构
[1] Great Ormond St Hosp Sick Children, London Ctr Paediat Endocrinol, London WC1N 3JH, England
[2] UCL, Inst Child Hlth, London WC1N 3JH, England
[3] St Batholomews & Royal London Sch Med & Dent, Dept Clin Pharmacol, London EC1M 6BQ, England
关键词
congenital adrenal hyperplasia; critical illness; hydrocortisone; cortisol clearance;
D O I
10.1136/adc.85.1.26
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background-Little is known of the optimal dose and administration schedule of hydrocortisone in critically ill patients with congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency. Aim-To determine plasma cortisol concentrations after intravenous administration of hydrocortisone in children with CAH and to relate these to plasma cortisol concentrations achieved by endogenous secretion in the stress of critical illness in previously healthy children. Methods-Plasma cortisol concentrations were measured in 20 patients with classical CAH (median age 11.2 years, range 6.1-16.4) following intravenous administration of hydrocortisone 15 mg/m(2); and in 60 critically ill mechanically ventilated children (median age 2.5 years, range 0.25-16.3) on admission to the paediatric intensive care unit and for 24 hours thereafter. Results-In the CAH patients, plasma cortisol reached a mean peak of 1648.3 nmol/l (SD 511.9) within 10 minutes of the intravenous bolus, and fell rapidly thereafter; levels remained greater than 450 nmol/l for 2.5 hours only. In critically iu children, mean plasma cortisol on admission to the intensive care unit was 727 nmol/l (SD 426.1). Cortisol concentrations remained raised during the first 24 hours. Conclusions-Critically ill patients with classical CAH may be best managed with a single intravenous hydrocortisone bolus followed by a constant rate infusion of hydrocortisone.
引用
收藏
页码:26 / 28
页数:3
相关论文
共 6 条
  • [1] BIRKETT DJ, 1998, PHARMACOKINETICS, P55
  • [2] Reversal of late septic shock with supraphysiologic doses of hydrocortisone
    Bollaert, PE
    Charpentier, C
    Levy, B
    Debouverie, M
    Audibert, G
    Larcan, A
    [J]. CRITICAL CARE MEDICINE, 1998, 26 (04) : 645 - 650
  • [3] Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
    Briegel, J
    Forst, H
    Haller, M
    Schelling, G
    Kilger, E
    Kuprat, G
    Hemmer, B
    Hummel, T
    Lenhart, A
    Heyduck, M
    Stoll, C
    Peter, K
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (04) : 723 - 732
  • [4] Adrenal insufficiency in septic shock
    Hatherill, M
    Tibby, SM
    Hilliard, T
    Turner, C
    Murdoch, IA
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (01) : 51 - 55
  • [5] Diagnosis and management of congenital adrenal hyperplasia
    New, MI
    [J]. ANNUAL REVIEW OF MEDICINE, 1998, 49 : 311 - 328
  • [6] Mortality in patients with congenital adrenal hyperplasia: A cohort study
    Swerdlow, AJ
    Higgins, CD
    Brook, CGD
    Dunger, DB
    Hindmarsh, PC
    Price, DA
    Savage, MO
    [J]. JOURNAL OF PEDIATRICS, 1998, 133 (04) : 516 - 520